179 related articles for article (PubMed ID: 37395989)
1. Bone metastatic cancer of unknown primary at initial presentation.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
[TBL] [Abstract][Full Text] [Related]
2. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
6. Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System.
Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
Cancer Epidemiol; 2023 Feb; 82():102316. PubMed ID: 36571909
[TBL] [Abstract][Full Text] [Related]
7. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
11. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
[TBL] [Abstract][Full Text] [Related]
12. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
[TBL] [Abstract][Full Text] [Related]
13. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
15. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
16. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
Song K; Song J; Chen F; Lin K; Ma X; Jiang J
Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018).
Wang S; Yin M; Wang P; Folefac E; Monk JP; Tabung FK; Clinton SK
Front Oncol; 2023; 13():1165188. PubMed ID: 37361592
[TBL] [Abstract][Full Text] [Related]
19. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
